The activation of mixed lineage kinase-like (MLKL) by receptor-interacting protein kinase-3 (RIPK3) controls the execution of necroptosis, a regulated form of necrosis that occurs in apoptosis-deficient conditions. Active oligomerized MLKL triggers the exposure of phosphatidylserine residues on the cell surface and disrupts the plasma membrane integrity by forming lytic pores. MLKL also governs the biogenesis and shedding of proinflammatory small extracellular vesicles (EVs) during the early steps of necroptosis, however the molecular basis is unknown. Here, we find that MLKL oligomers activate plasma membrane Pannexin-1 (PANX1) channels, concomitantly to the loss of phosphatidylserine asymmetry. This plasma membrane "leakiness" requires the Rab GTPase Rab27 isoforms, which usher the small EVs to their release. Conversely, PANX1 knockdown disorganized the small EVs machinery and precludes vesicles extrusion. These data identify a novel signaling nexus between MLKL, Rab27, and PANX1, and propose ways to interfere with small EV generation.
INTRODUCTION
Necroptosis is a programmed lytic cell death pathway that occurs in apoptosis-deficient conditions [1] . In contrast to apoptosis, which is immunologically silent as cellular content remains impermeable and is rapidly engulfed by surrounding phagocytic cells, necroptotic cells produce proinflammatory cytokines and release cytosolic proinflammatory material in the extracellular milieu as a consequence of the loss of plasma membrane (PM) integrity [2] . Although the engagement of several immunoreceptors culminate in necroptosis, this form of death has been best studied upon ligation of the death receptor family member TNF receptor 1 (TNFR1) [2] . When caspases are blocked, TNFR1 signaling assembles a filamentous deathinducing complex of the Ser/Thr kinases RIPK1, RIPK3 and the pseudokinase MLKL coined necrosome, which culminates in the phosphorylation of MLKL by RIPK3 [3] [4] [5] [6] [7] [8] [9] . This causes MLKL to adopt a conformational change required for its multimerization [10] . The binding of negatively charged phospholipids such as high-order inositol phosphates to oligomerized MLKL
Pannexin-1 governs Plasma Membrane "Leakiness"
This "leakiness" of necroptotic cells is reminiscent of the caspase-mediated opening of PM PANX1 hemichannels during apoptosis, as evidence by the selective uptake of TO-PRO-3 [21] . This results in the release of purines, such as ATP in the extracellular space, which serve as a "find-me" signal for surrounding phagocytes [21] . To test the impact of PANX1 on "leakiness" during necroptosis, we first knocked down its expression with siRNA and found no overt impact on the phosphorylation of the necrosome core components RIPK1, RIPK3 and MLKL ( Fig. 2A ). Of note, we observed the appearance of a shorter MLKL fragment 4-6 hours post-stimulation, which was PANX1-dependent ( Fig. 2A and 2B) . The size of the generated fragment and the specificity of antibodies used (Fig. S1 ) suggested a cleavage between the brace region and the pseudokinase domain of MLKL [22] (see below). Nevertheless, oligomerization of MLKL occurred normally in PANX1-silenced cells, and was efficiently blocked by pre-treating cells with Nec-1s ( Fig. 2B ). In line with this, no significant change in the accumulation of phospho-MLKL at the PM was observed (Fig. 2C ). Moreover, PANX1 silencing did not alter necroptotic death (Fig. 2D ). Accordingly, MLKL-mediated flip of PS occurred normally without PANX1, reinforcing the idea that PANX1 is dispensable for cell death by necroptosis ( Fig. 2E and 2F ). In contrast, silencing PANX1 was as efficient as knocking down MLKL in preventing TO-PRO-3 uptake ( Fig. 2E and 2F ). Importantly, similar results were obtained in cells treated with the PANX1 pharmacologial inhibitor Trovafloxacin [23] (Fig. 2G-I) . Collectively, these data demonstrate that MLKL initiates "leakiness" of the PM via PANX1, and that PANX1 activation is dispensable for the exposure of PS during necroptosis.
During apoptosis, effector caspases remove a COOH-terminal inhibitory domain of PANX1 to irreversibly open the channels [21] . The analysis of PANX1 by immunoblotting revealed multiple species, consistent with N-glycosylation, as they were efficiently removed with a treatment with PNGase F ( [24] , Fig. 2A, and Fig. S2A ). Although less dramatic than during apoptosis [21, 25] , PANX1 was also cleaved during necroptosis at a site close to the characterized caspase site, as evidenced by a slight decrease in full-length PANX1 combined with the presence of a cleaved fragment in PNGase F-treated samples ( Fig. 2A, 2G and S2A). Conversely, the canonical caspase substrate PARP remained intact, arguing against residual caspase activity ( Fig. S2A and S2B ). Importantly, PANX1 proteolysis was significantly reduced in Trovafloxacin-treated cells during necroptosis but not apoptosis (Fig. 2G, S2B and S2C) . Similarly, MLKL processing was hampered when PANX1 was silenced, or when its activity was blocked ( Fig. 2A, 2B , and 2G). Hence, the cleavage of MLKL and PANX1 likely results from the opening of the channel in necroptotic cells.
MLKL Oligomerization controls Plasma Membrane "Leakiness"
Once phosphorylated by RIPK3, MLKL binds high-order inositol phosphates [11] . This displaces MLKL's auto-inhibitory domain and allows MLKL to oligomerize and reach the plasma membrane to exert its lethal function [11, 12] . As expected [3, 12] , the treatment of cells with the small molecule necrosulfonamide (NSA) prevented MLKL oligomerization (Fig. 3A ). NSA also significantly reduced the uptake of TO-PRO-3 ( Fig. 3B and S3A ). We next silenced inositoltetrakisphosphate 1-kinase (ITPK1), a crucial kinase for the generation of inositol phosphates [11] . Although RIPK1, RIPK3, and MLKL were phosphorylated, the processing of MLKL and PANX1 no longer occurred without ITPK1 (Fig. 3C ). In agreement with Dovey et al [11] , silencing ITPK1 precluded MLKL oligomerization ( Fig. 3D ). This led to a reduction in the exposure of PS residues together with a significant inhibition of TO-PRO-3 uptake ( Fig. 3E and 3F). Thus, MLKL oligomerization is instrumental for "leakiness" of the PM.
Interplay between the small EVs Machinery and Pannexin-1 during Necroptosis
In addition to triggering cell death, active MLKL enables the generation of small EVs and their shedding from necroptotic cells [15, 18] . To test whether the small EVs machinery contributes to "leakiness" during necroptosis, we focused on Rab27a and Rab27b, as this subfamily of Rab GTPases facilitates the docking and fusion to the PM of multivesicular bodies (MVBs), which are enriched with ILVs [26] . First, 100,000 x g (100k) sedimented membrane vesicles fractions, purified from culture media of Rab27a-or Rab27b-silenced cells, were analyzed by tunable resistive pulse sensing technology ( Fig. 4A ). Supporting previous works [15, 18] , the triggering of necroptosis increased small EVs release and this was markedly reduced when Rab27a or Rab27b were knocked down. Silencing Rab27a did not alter classical hallmarks of necroptosis, such as RIPK1 and MLKL phosphorylation or MLKL oligomerization, whereas PS exposure and overall cell death were slightly reduced ( Fig. 4B -D, and Fig. S5 ). Yet, the proteolysis of MLKL and PANX1, as well as the uptake of TO-PRO-3 were drastically reduced without Rab27a ( Fig. 4B -D). Because Rab27a is also instrumental for lysosomal biology [27] , we assessed whether interfering with the lysosomes prevents MLKL processing. However, the inhibition of either the vacuolar H + ATPase with Bafilomycin A1 and concanamycin A, or of cathepsins had no gross effect on PANX1-mediated MLKL proteolysis ( Fig. S4 ). Of note, the knockdown of Rab27b also prevented PM "leakiness" while sparing MLKL activation during necroptosis ( Fig. 4E -G, and Fig. S5 ). Combined, this data suggests that oligomerized MLKL initiates PS asymmetry independently of the small EV machinery. However, the Rab27-dependent generation of small EVs appears crucial for the activation of PANX1 channels and "leakiness".
Pannexin-1 participates in the Intracellular Trafficking and the Secretion of small EVs
This connection between MVBs maturation and PANX1 prompted us to investigate the role of PANX1 in the release of small EVs. First, small EVs were purified from early necroptotic cells by ultracentrifugation (100k) and analyzed by immunoblot ( Fig. 5A ). As expected [15, 18] , necroptosis-induced small EVs release was MLKL-dependent, as evidence by staining the exosomal marker ALIX (Fig. 5A ). In addition, PANX1, MLKL, and cleaved MLKL were also present in the 100k fraction upon necroptosis. Of note, the PANX1 band appeared slightly smaller, suggesting that it may be cleaved PANX1. Paralleling MLKL knockdown, silencing PANX1 also prevented the accumulation of the small EVs marker ALIX ( Fig. 5B ). Consistent with these biochemical analyses, the concentration of released vesicles was severely reduced without MLKL or PANX1, as measured by tunable resistive pulse sensing technology ( Fig. 5C ). Combined, these results suggest that PANX1 selectively controls the regulated secretion of small EVs during necroptosis.
The absence of MLKL was shown to reduce the biogenesis of ILVs, and their constitutive release in the extracellular milieu [18] . The size and intracellular distribution of ILVs/MVBs is also significantly rearranged without Rab27 proteins [26] . To gain further insight into the mechanism responsible for the reduced small EVs release in PANX1-silenced cells, we first monitored, by confocal microscopy, the subcellular distribution of CD63, a tetraspanin enriched in ILVs [26] . This showed that PANX1-silenced cells phenocopied Rab27b knockdown and displayed an asymmetrical perinuclear accumulation of CD63-positive structures in HeLa cells ( Fig. 5D -F, and Movies S3-S7). Of note, these CD63-positive vesicles clustered in closed proximity to the Golgi. The size and morphology of these structures were further analyzed by super-resolution microscopy. Supporting Ostrowski et al [26] , Rab27a silencing, and not Rab27b knockdown, increased the number and the size heterogeneity of CD63-positive vesicles ( Fig. 5G , 5H, and S6). By contrast, the number of vesicles dropped without MLKL, consistent with a defect in ILVs biogenesis [18] . Without PANX1, we observed a significant reduction in the number of CD63positive structures, although their volume was not overtly changed ( Fig. 5G , 5H, and S6). Altogether, these findings support the idea that PANX1, along with MLKL and the Rab27 proteins, contributes to the biogenesis and intracellular trafficking of small EVs.
DISCUSSION
Here, we provide evidence that PANX1 channels operate downstream of MLKL to favor necroptosis-driven release of small EVs ( Fig. S8 ). Our data also illustrate how the PM of necroptotic cells undergoes drastic rearrangements before it collapses. This includes the insertion of MLKL oligomers [10-14], PS scrambling, ions fluxes [13,28], activation of cell surface proteases [29] , the release of small "bubbles" of broken PM [16] , and PANX1-mediated uptake of dye and small EVs release. Although PANX1 silencing only marginally affected PS asymmetry, additional work is required to elucidate whether PS externalization is a prerequisite for PM "leakiness", or if MLKL signaling bifurcates.
How exactly is MLKL linked to PANX1? MLKL oligomers target intracellular compartments, in addition to the PM [3]. Whether MLKL's location dictates its apparently independent functions remains unknown. Nevertheless, our results indicate that MLKL oligomers-mediated activation of PANX1 hemichannels requires the small EVs machinery. Future investigations will define how precisely docking and fusion of MVBs to the PM is propitious for PM "leakiness". In addition to mechanical stretches, ATP, K + efflux, Ca 2+ influx, phosphorylation, or caspase-mediated processing of its COOH-terminal intracellular latch were shown to open PANX1 channels [30] . Of note, oligomerized MLKL promotes a drastic efflux of potassium in bone marrow-derived macrophages, which culminates in the activation of the NLRP3 inflammasome [31] . However, buffering the concentration of K + with KCl at concentrations that did not interfere with MLKL phosphorylation (Ref. [31] ) had no clear impact on PANX1-mediated uptake of TO-PRO-3 and processing of MLKL ( Fig. S7 ). Although not formally ruled out here, MLKL-dependent Ca 2+ flux was shown to occur rather lately in necroptotic HT-29 cells, concomitantly to the loss of PM integrity [28] . Intriguingly, we noted that PANX1 and MLKL were cleaved by non-caspase proteases in a PANX1-dependent manner during necroptosis. Proteases contained in small EVs may be involved [32] . Interestingly, MLKL phosphorylation and PS asymmetry do not mark a point-of-no-return and both events can be reversed if the insult is removed [15] [16] [17] . Because "leakiness" occurs concomitantly to PS exposure, it is tempting to speculate that PANX1 opening during necroptosis is also reversible.
In addition to convey material for intercellular communication, necroptotic small EVs were proposed to counteract cell death by expelling lethal molecules such as active MLKL [18] . However, we find that curbing EVs release downstream of MLKL, by targeting Rab27a, Rab27b or PANX1 did not change the overall threshold for necroptotic death. Instead, we observed a slight reduction in cell death without Rab27 isoforms. During apoptosis, the presence of PS on the outer leaflet of the PM, combined with the opening of PANX1 hemichannels serve as "eat-me" and "find-me" signals to favor silent phagocytosis [21, 23, 33] . Caspase-mediated activation of PANX1 also coordinates the release of apoptotic bodies and prevents the formation of "stringlike" protrusion called apoptopodia [23, 34] . During necroptosis, the release in the extracellular milieu of "danger signals" from dying cells, together with ATP and small EVs drive inflammation [35] . Our data linking PANX1 to the biogenesis and release of small EVs suggest that tuning of PANX1 activity may shape the necroptotic microenvironment. The necroptotic machinery has been linked to several inflammatory conditions such as ischemia/reperfusion, inflammatory neurodegenerative diseases, intestinal inflammation, and cancer [1, 36, 37] . Strategies aimed at targeting PANX1 might be relevant to selectively modulate cell death-independent functions of MLKL.
MATERIALS AND METHODS Cell Culture and Reagents
HT-29 and HeLa cells were purchased from the American Type Culture Collection. Bafilomycin A1, Concanamycin A, Cycloheximide, and Trovafloxacin were purchased from Sigma. Q-VD-OPh, Tumor necrosis factor-alpha (TNFa) were obtained from R&D Systems. Cathepsin Inhibitor 1 (S2847), Birinapant, Necrostatin-1 (Nec-1s), and Necrosulfonamide (NSA) were from Selleckchem. MCC-950 (Invivogen), TO-PRO-3, Alexa-488 Annexin V, and propidium iodide (Life Technologies), CellTiter-Glo and PGNase F (Promega), and Cytotoxicity Detection kit PLUS (Roche Diagnostics) were also used.
siRNA, and Transfections
Cells were transfected with 10 pmol of siRNA using the Lipofectamine RNAiMAX Transfection Reagent (Invitrogen). The following sequences were obtained from Life Technologies: ITPK1, AGAUCCUGUCGUCUUCCAUGUAGGC (HSS105602); MLKL, GCAACGCAUGCCUGUUUCACCCAUA (HSS136796); PANX1, AUAUGAAUCCACAAAGGCAGCCUGA (HSS119236). A mixture of siRNAs targeting Rab27a was purchased from Sigma (EHU91501). Rab27b was silenced as previously published [38]: TAGGAATAGACTTTCGGGAAA.
Cell Death Induction and Measurement
To induce necroptosis, HT-29 cells were pre-treated 30-60 min with 10 µM Q-VD-OPH plus 5 µM Birinapant prior stimulation with 0-10 ng.mL -1 of TNFa. In some experiments, Nec-1s (20 µM), Trovafloxacin (30 µM), NSA (5 µM) and cycloheximide (10 µM) were used. Cell viability was assessed using CellTiter-Glo, staining with Crystal violet, and staining with Annexin V and TO-PRO-3, following the manufacturer instructions.
Western Blotting Analysis and Antibodies
Cells were washed with ice-cold PBS and lysed with TNT buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% Igepal, 2 mM EDTA] or with RIPA buffer [25 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% SDS, 0.5% Na-Deoxycholate, 1% NP40, 1 mM EDTA] supplemented with protease inhibitors (ThermoFisher Scientific) for 30 min on ice. Extracts were cleared by centrifugation at 9,000 x g and protein concentration determined by BCA (ThermoFisher Scientific). 5-10 µg proteins were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membranes (GE Healthcare). To visualize MLKL oligomers, protein cross-linking was performed as previously described [39] . Briefly, cells were fixed in PBS containing 0.4% paraformaldehyde for 12 min at room temperature and lysed with PBS containing 1% Triton-X100 and proteases inhibitors. Proteins were incubated with 2X Laemmli buffer (Life Technologies) at room temperature and separated by SDS-PAGE. Antibodies specific for the following proteins were purchased from Cell Signaling Technology: MLKL (D216N), P-MLKL S 358 (D6H3V), PANX1 (D9M1C), Rab27a (D7V6B), P-RIPK1 S 166 (D1L3S), RIPK3 (E1Z1D), and P-RIPK3 S 227 (D6W2T). Antibodies specific for GAPDH (6C5), and PARP (F-2) were purchased from Santa Cruz Biotechnology. Antibodies specific for GM130 (ab52649), and for MLKL (ab183770) were purchased from Abcam. Antibodies against RIPK1 (BD Biosciences, 51), against MLKL (Millipore, MABC604), against ALIX (Biolegend, 3A9), against ITPK1 (Sigma, HPA055230), against CD63 (SBI, EXOAB A-1), and against Rab27b (Proteintech, 13412-1-AP) were also used.
Immunofluorescence Microscopy
HT-29 grown on coverslips were fixed with PBS containing 4% paraformaldehyde for 30 min at room temperature, and staining was performed as previously described [11] . Briefly, fixed samples were incubated at 4°C overnight with primary antibodies and 60 minutes with secondary antibodies in PBS containing 3% BSA, 1% saponin, and 1% Triton X-100). The following antibodies were used: anti-CD63 (556019, BD Biosciences), anti-P-MLKL S358/T357 (Abcam, ab187091), anti-GM130 (Abcam, ab52649). Alexa-568 Phalloidin (Life Technologies) was used to stain actin. Coverslip were sealed with Prolong gold anti-fade mouting media (Life Technologies) that allowed illumination of the nuclei by DAPI staining. For confocal microscopy, images were acquired with a Nikon A1R confocal microscope using the NIS-Element Software and processed using the FIJI Software. Structure illumination microscopy (SIM) images were acquired with a Nikon N-SIM microscope. Z-stacks of 0.12 µm were performed using a 100x oilimmersion lens with a 1.49 numerical aperture and reconstructed in 3D using the NIS-Element Software. Reconstructed images with a maximal NIS score of 8 were further analyzed. For live imaging, transfected HT-29 cells were pre-treated with Q-VD-OPh, Birinapant and incubated with TO-PRO-3 and Annexin V. After 30 minutes, TNFa was added and images were recorded every 5 minutes for 8 hrs. Acquisition and analysis were performed on a Leica Timelapse DMI-8 using the MetaMorph software (version 7.5) (MicroPicell, SFR François Bonamy, France).
Image Analysis
Reconstructed images validated with the SIMcheck plugin 1.2 were analyzed with Fiji ImageJ2 v1.52i [40] . A binary mask was applied to select images with a modulation contrast-to-noise ratio (MCNR) > 8. Individual spots corresponding to single CD63-positive structure were isolated with the classic watershed function of the MorpholibJ plugin [41] and pixels intensity was measured. Only structures with the MCNR > 12 were retained ( Fig. S8 ).
Small Extracellular Vesicles Analysis
Small EVs were purified as previously described [42] . Briefly, to avoid contamination with extracellular vesicles (EVs) from the FBS, serum was centrifuged at 100,000 x g for 16 hrs on a Beckman Coulter ultracentrifuge using the SW-41 Ti rotor. EVs were purified from the conditional media of 0.4 x 10 6 transfected HT-29 cells via successive centrifugations (300 x g 5 min, 2,000 x g 10 min, 10,000 x g 30 min, 100,000 x g 2h). Pellets were washed in PBS-0.22 µm filtered, re-centrifuged at 100,000 x g for 2 hours and resuspended in a small volume of PBS-0.22 µm filtered. 100,000 x g steps were performed on a Beckman Coulter Centrifuge using the MLA-130 rotor. Diameter and concentration of the particles were determined by Tunable Resistive Pulse Sensing (TRPS) using the qNano system (IZON). Particles within the range of 50-330 nm were detected using the pore "NP 100". A stretch 46 mm was applied to the pores with an appropriate voltage (0.80Ω-1.00V) to reach a 120 nA baseline with noise < 10 pA. For Western Blot analysis, the following antibodies and concentrations were used: ALIX (Biolegend, 3A9; 1:1000), GM130 (ab52649; 1:2000), MLKL (ab183770; 1:1000) and PANX1 (D9M1C, 1:1000). We have submitted all relevant data of our experiments to the EV-TRACK knowledgebase (EV-TRACK ID: EV180073) [43].
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 7 software using one-way and twoway analysis (ANOVA). Fig. S1 . MLKL processing during necroptosis. Fig. S2 . PANX1 cleavage occurs secondarily to PANX1 activation. Fig. S3 . Necrosulfonamide inhibition of TO-PRO-3 uptake. Fig. S4 . MLKL cleavage is not affected by lysosome inhibitors. Fig. S5 . Differential impact of PANX1, Rab27a, and Rab27b on cell survival. Fig. S6 . Effect of MLKL, PANX1, Rab27a, and Rab27b on CD63-positive structures. Fig. S7 . High concentrations of potassium chloride do not alter PANX1 activation and MLKL processing. (A), HT-29 cells were transfected with a nonspecific (NS) siRNA or with Rab27a-and Rab27b-specific siRNAs for 72 hrs. Cells were pre-treated with 10 µM QVD-OPh (Q) plus 5 µM Birinapant (S), and exposed to 10 ng.mL -1 of TNFa (T) for 5 hours. Small EVs fractions were purified from the culture medium by ultracentrifugation. Shown is a representative diagram of particle count obtained with tunable resistive pulse sensing analysis (TRPS, qNano, IZON). HT-29 cells were transfected with a nonspecific (NS) siRNA or with the indicated siRNAs for 72 hrs. Cells were pre-treated with 10 µM QVD-OPh (Q) plus 5 µM Birinapant (S), and exposed to 10 ng.mL -1 of TNFa (T) for 6 hours. (A and B, small EVs were prepared and subjected to Western blotting analysis with antibodies specific for the indicated proteins. The Golgi resident protein GM130 served as a purity marker. Cleaved MLKL is indicated with an arrowhead, and molecular weight markers (Mr) are shown. C, Diagram of size distribution in small EVs fractions from NS-, PANX1-, and MLKL-silenced cells, obtained with tunable resistive pulse sensing (TRPS, qNano, IZON). D and E, Confocal microscopic analysis of CD63 (D), or CD63 and GM130 (E) in HeLa cells, as indicated. In (E), staining was analyzed by Structure Illumination microscopy (SIM). Nuclei were counterstained with DAPI. F, The percentage of cells with an asymmetric distribution of CD63 was determined in three independent experiments. Data are means ± SEM (*P<0.1, ****P<0.0001, ANOVA). G and H, Quantification of the volumes of CD63-positive structures (G), or scatter plots of numbers and mean volumes of CD63-positive structures analyzed by SIM (n=10 cells per condition; **P<0.05, ****P<0.0001; ANOVA). Ellipses show 95% confidence. The presented data are representative of at least three independent experiments. Control non-specific (NS) or MLKL-silenced HT-29 were pre-treated with 5 µM NSA, 30 µM Trovafloxacin (Trova), 100 ng.mL -1 Bafilomycin A1, 10 nM concanamycin A1, 10 µM Cathepsin inhibitor 1, and necroptosis was triggered, as in Figure 1 . MLKL processing was analysed by Western Blotting, as indicated. Molecular weight markers (Mr) are shown. Figure S5 . Differential Impact of PANX1, Rab27a, and Rab27b on Cell Survival. HT-29 cells were transfected with siRNA for PANX1, Rab27a, Rab27b, or scramble non-specific (NS) siRNA for 72 hrs. Cells were pre-treated with 10 µM QVD-OPh (Q) together with 5 µM Birinapant (S), prior stimulation with 10 ng.mL -1 of TNFa (T) for 24 h. Necrostatin-1 (Nec-1s, 20 µM) was also used. A, Cell viability assay by CellTiter-Glo (mean ± SEM, n=8, *P<0.1, **P<0.01, ****P<0.0001, ANOVA). B, Flow cytometric analysis of cells stained with Propidium Iodide (PI). Shown is mean ± SEM (n=6, ****P<0.0001, ANOVA). 
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